Docstoc

Investor Notice: The Rosen Law Firm Announces Investigation of Shareholder Securities Claims Against AspenBio Pharma, Inc. --- APPY

Document Sample
Investor Notice: The Rosen Law Firm Announces Investigation of Shareholder Securities Claims Against AspenBio Pharma, Inc. --- APPY Powered By Docstoc
					Investor Notice: The Rosen Law Firm Announces
Investigation of Shareholder Securities Claims
Against AspenBio Pharma, Inc. --- APPY
September 03, 2010 08:06 PM Eastern Daylight Time  

NEW YORK--(EON: Enhanced Online News)--The Rosen Law Firm today announced that it has commenced an
investigation into allegations that AspenBio Pharma, Inc. (“AspenBio” or the “Company”) (Nasdaq: APPY - News)
violated the federal securities laws by issuing false and misleading statements to investors about its product candidate
AppyScore.

Since as early February 15, 2006, AspenBio has been touting AppyScore as an effective test to diagnose
appendicitis. On June 7, 2010, the Company disclosed there was “unexplained variability” in the test results of its
most recent clinical trial for AppyScore. Then, on July 19, 2010, the Company disclosed more details showing that
the AppyScore was not effective at detecting appendicitis because, among other things, the test could not
differentiate between appendicitis and other medical conditions. This adverse news caused the Company’s stock to
drop substantially and investors have suffered significant losses.

As a result of these allegations, the Rosen Law Firm is preparing a class action lawsuit on behalf of investors who
suffered losses purchasing AspenBio stock.

You may access the website at http://www.rosenlegal.com to participate in the proposed class action.

If you purchased AspenBio securities and would like further information concerning your legal rights or your ability to
recover your investment losses, please contact Laurence Rosen, Esq. or Phillip Kim, Esq. toll-free at 866-767-3653
or email lrosen@rosenlegal.com or pkim@rosenlegal.com or visit the website at www.rosenlegal.com

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions
and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts
The Rosen Law Firm P.A.
Laurence Rosen, Esq.
Phillip Kim, Esq.
212-686-1060
Weekends Tel: 917-797-4425
Toll Free: 1-866-767-3653
Fax: 212-202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
www.rosenlegal.com

Permalink: http://eon.businesswire.com/news/eon/20100903005787/en

				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:29
posted:9/4/2010
language:English
pages:1
Description: NEW YORK--(EON: Enhanced Online News)--The Rosen Law Firm today announced that it has commenced an investigation into allegations that AspenBio Pharma, Inc. (“AspenBio” or the “Company”) (Nasdaq: APPY - News) violated the federal securities laws by issuing false and misleading statements to investors about its product candidate AppyScore. Since as early February 15, 2006, AspenBio has been touting AppyScore as an effective test to diagnose appendicitis. On June 7, 2010, the Company disclosed the a style='f
EON: Enhanced Online News EON: Enhanced Online News http://eon.businesswire.com
About At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.